A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSamsung Medical Center

About this trial

The investigators will prospectively collect clinical information to develop a clustering analysis model and confirm phenotype for patients with acute respiratory failure who admit to the intensive care unit and require oxygen supply beyond a high flow nasal cannula, and a control group without acute respiratory failure. and clinical characteristics and prognosis will be compared.

Eligibility criteria

Qualifiers

Age 18 or older

Patients who do not require high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) treatment

Disqualifiers

Patients 48 hours after oxygen treatment (HFNC, NIV (BIPAP or CPAP), MV)

Patients transferred from another hospital

Patients with limitations in treatment

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

250 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Samsung Medical Center

Lead sponsor

Ministry of Science and ICT, Republic of Korea

Collaborator